2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Dilatation, Pathologic: new trials by email Literature Review of Dilatation, Pathologic trials Research Report on Dilatation, Pathologic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intrauterine Lidocaine for Laminaria Lidocaine, Normal Saline - Abortion, Induced, Pain Management | Phase 1 | Completed | University of North Carolina, Chapel Hill | 72 | 2012-09-01 | 2014-05-14 |
| Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide SMS995, Placebo - Irritable Bowel Syndrome (IBS) | Phase 1 | Completed | Novartis | 50 | 2008-01-01 | 2009-05-08 |
Agnosia (1) · Irritable Bowel Syndrome (1) · Syndrome (1)
Pathological Conditions, Anatomical (2) · Pathological Conditions, Signs and Symptoms (2) · Colonic Diseases (1) · Colonic Diseases, Functional (1) · Digestive System Diseases (1) · Disease (1) · Gastrointestinal Diseases (1) · Intestinal Diseases (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · Pathologic Processes (1) · Perceptual Disorders (1) · Signs and Symptoms (1)
Lidocaine (1) · Octreotide (1) · Saline Solution (1)
Novartis (1) · University of North Carolina, Chapel Hill (1)
United States (2) · Canada (1) · Sweden (1) · United Kingdom (1)